Klag T - Search Results

1

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.

La Rosée P, Martiat P, Leitner A, Klag T, Müller MC, Erben P, Schenk T, Saussele S, Hochhaus A. La Rosée P, et al. Among authors: klag t. Ann Hematol. 2013 Oct;92(10):1345-50. doi: 10.1007/s00277-013-1769-2. Epub 2013 Apr 28. Ann Hematol. 2013. PMID: 23625298

2

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors.

Klag T, Härtel N, Erben P, Schwaab J, Schnetzke U, Schenk T, Hochhaus A, La Rosée P. Klag T, et al. Leukemia. 2012 Jun;26(6):1321-8. doi: 10.1038/leu.2011.380. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289991

3

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.

Härtel N, Klag T, Hanfstein B, Mueller MC, Schenk T, Erben P, Hochhaus A, La Rosée P. Härtel N, et al. Among authors: klag t. J Cancer Res Clin Oncol. 2012 Feb;138(2):203-12. doi: 10.1007/s00432-011-1086-x. Epub 2011 Nov 17. J Cancer Res Clin Oncol. 2012. PMID: 22089930

4

Leriche's syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome.

Klag T, Schnetzke U, Benz R, Zanow J, Glaser A, Pörner TC, Scholl S, Reiter A, Hochhaus A, La Rosée P. Klag T, et al. Ann Hematol. 2012 Jan;91(1):139-41. doi: 10.1007/s00277-011-1232-1. Epub 2011 Apr 15. Ann Hematol. 2012. PMID: 21494797 No abstract available.

5

Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria.

Saman S, Goetz M, Wendler J, Malek NP, Wehkamp J, Klag T. Saman S, et al. Among authors: klag t. Intest Res. 2019 Jul;17(3):340-348. doi: 10.5217/ir.2019.00012. Epub 2019 May 31. Intest Res. 2019. PMID: 31129948 Free PMC article.

6

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.

Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.

7

Quality of life in inflammatory bowel diseases: it is not all about the bowel.

Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, Enck P, Klag T. Keller R, et al. Among authors: klag t. Intest Res. 2021 Jan;19(1):45-52. doi: 10.5217/ir.2019.00135. Epub 2020 Feb 27. Intest Res. 2021. PMID: 32093437 Free PMC article.

8

Management of Crohn's disease - are guidelines transferred to clinical practice?

Klag T, Stange EF, Wehkamp J. Klag T, et al. United European Gastroenterol J. 2015 Aug;3(4):371-80. doi: 10.1177/2050640615580228. United European Gastroenterol J. 2015. PMID: 26279846 Free PMC article.

9

Medical Therapy of Perianal Crohn's Disease.

Klag T, Goetz M, Stange EF, Wehkamp J. Klag T, et al. Viszeralmedizin. 2015 Aug;31(4):265-72. doi: 10.1159/000434664. Epub 2015 Jul 29. Viszeralmedizin. 2015. PMID: 26557835 Free PMC article. Review.

10

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.

Klag T, Mazurak N, Fantasia L, Schwille-Kiuntke J, Kirschniak A, Falch C, Goetz M, Malek NP, Enck P, Wehkamp J. Klag T, et al. Inflamm Bowel Dis. 2017 Oct;23(10):1796-1802. doi: 10.1097/MIB.0000000000001216. Inflamm Bowel Dis. 2017. PMID: 28817460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters